501 related articles for article (PubMed ID: 33309844)
1. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
[TBL] [Abstract][Full Text] [Related]
2. Directly Compressed Tablets: A Novel Drug-Containing Reservoir Combined with Hydrogel-Forming Microneedle Arrays for Transdermal Drug Delivery.
McAlister E; Dutton B; Vora LK; Zhao L; Ripolin A; Zahari DSZBPH; Quinn HL; Tekko IA; Courtenay AJ; Kelly SA; Rodgers AM; Steiner L; Levin G; Levy-Nissenbaum E; Shterman N; McCarthy HO; Donnelly RF
Adv Healthc Mater; 2021 Feb; 10(3):e2001256. PubMed ID: 33314714
[TBL] [Abstract][Full Text] [Related]
3. Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride.
Migdadi EM; Courtenay AJ; Tekko IA; McCrudden MTC; Kearney MC; McAlister E; McCarthy HO; Donnelly RF
J Control Release; 2018 Sep; 285():142-151. PubMed ID: 29990526
[TBL] [Abstract][Full Text] [Related]
4. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate.
Tekko IA; Chen G; Domínguez-Robles J; Thakur RRS; Hamdan IMN; Vora L; Larrañeta E; McElnay JC; McCarthy HO; Rooney M; Donnelly RF
Int J Pharm; 2020 Aug; 586():119580. PubMed ID: 32593650
[TBL] [Abstract][Full Text] [Related]
5. Hydrogel-forming microneedles prepared from "super swelling" polymers combined with lyophilised wafers for transdermal drug delivery.
Donnelly RF; McCrudden MT; Zaid Alkilani A; Larrañeta E; McAlister E; Courtenay AJ; Kearney MC; Singh TR; McCarthy HO; Kett VL; Caffarel-Salvador E; Al-Zahrani S; Woolfson AD
PLoS One; 2014; 9(10):e111547. PubMed ID: 25360806
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a dry reservoir-hydrogel-forming microneedles composite for minimally invasive delivery of cefazolin.
Sabri AHB; Anjani QK; Utomo E; Ripolin A; Donnelly RF
Int J Pharm; 2022 Apr; 617():121593. PubMed ID: 35182702
[TBL] [Abstract][Full Text] [Related]
7. Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery.
Courtenay AJ; McAlister E; McCrudden MTC; Vora L; Steiner L; Levin G; Levy-Nissenbaum E; Shterman N; Kearney MC; McCarthy HO; Donnelly RF
J Control Release; 2020 Jun; 322():177-186. PubMed ID: 32200001
[TBL] [Abstract][Full Text] [Related]
8. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery.
Garland MJ; Caffarel-Salvador E; Migalska K; Woolfson AD; Donnelly RF
J Control Release; 2012 Apr; 159(1):52-9. PubMed ID: 22265694
[TBL] [Abstract][Full Text] [Related]
9. Novel SmartReservoirs for hydrogel-forming microneedles to improve the transdermal delivery of rifampicin.
Abraham AM; Anjani QK; Adhami M; Hutton ARJ; Larrañeta E; Donnelly RF
J Mater Chem B; 2024 May; 12(18):4375-4388. PubMed ID: 38477350
[TBL] [Abstract][Full Text] [Related]
10. Development, Evaluation, and Pharmacokinetic Assessment of Polymeric Microarray Patches for Transdermal Delivery of Vancomycin Hydrochloride.
Ramadon D; Permana AD; Courtenay AJ; McCrudden MTC; Tekko IA; McAlister E; Anjani QK; Utomo E; McCarthy HO; Donnelly RF
Mol Pharm; 2020 Sep; 17(9):3353-3368. PubMed ID: 32706591
[TBL] [Abstract][Full Text] [Related]
11. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays.
Garland MJ; Migalska K; Tuan-Mahmood TM; Raghu Raj Singh T; Majithija R; Caffarel-Salvador E; McCrudden CM; McCarthy HO; David Woolfson A; Donnelly RF
Int J Pharm; 2012 Sep; 434(1-2):80-9. PubMed ID: 22669101
[TBL] [Abstract][Full Text] [Related]
12. Considerations in the sterile manufacture of polymeric microneedle arrays.
McCrudden MT; Alkilani AZ; Courtenay AJ; McCrudden CM; McCloskey B; Walker C; Alshraiedeh N; Lutton RE; Gilmore BF; Woolfson AD; Donnelly RF
Drug Deliv Transl Res; 2015 Feb; 5(1):3-14. PubMed ID: 25787335
[TBL] [Abstract][Full Text] [Related]
13. Novel in situ forming hydrogel microneedles for transdermal drug delivery.
Sivaraman A; Banga AK
Drug Deliv Transl Res; 2017 Feb; 7(1):16-26. PubMed ID: 27562294
[TBL] [Abstract][Full Text] [Related]
14. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.
McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF
J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420
[TBL] [Abstract][Full Text] [Related]
15. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Skin Permeation Enhancement of Sumatriptan by Microneedle Application.
Nalluri BN; Anusha SS; Bramhini SR; Amulya J; Sultana AS; Teja CU; Das DB
Curr Drug Deliv; 2015; 12(6):761-9. PubMed ID: 25739035
[TBL] [Abstract][Full Text] [Related]
18. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
Donnelly RF; Garland MJ; Alkilani AZ
Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
[TBL] [Abstract][Full Text] [Related]
19. Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.
González-Vázquez P; Larrañeta E; McCrudden MTC; Jarrahian C; Rein-Weston A; Quintanar-Solares M; Zehrung D; McCarthy H; Courtenay AJ; Donnelly RF
J Control Release; 2017 Nov; 265():30-40. PubMed ID: 28754611
[TBL] [Abstract][Full Text] [Related]
20. Transdermal Delivery of Pramipexole Using Microneedle Technology for the Potential Treatment of Parkinson's Disease.
McGuckin MB; Hutton ARJ; Davis ER; Sabri AHB; Ripolin A; Himawan A; Naser YA; Ghanma R; Greer B; McCarthy HO; Paredes AJ; Larrañeta E; Donnelly RF
Mol Pharm; 2024 May; 21(5):2512-2533. PubMed ID: 38602861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
